COHERA MEDICAL TISSUGLU SURGICAL ADHESIVE

FDA Premarket Approval P130023 S005

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for a modification to the tissuglu® synthesis process where a small percentage of the stability reagents (sulfuric acid and dmso stock solution) that are normally added at the end of the product synthesis process is instead added at the beginning of synthesis ("borrowed acid process").

DeviceCOHERA MEDICAL TISSUGLU SURGICAL ADHESIVE
Generic NameTissue Adhesive For Internal Use
ApplicantCOHERA MEDICAL, INC
Date Received2017-01-26
Decision Date2017-07-27
PMAP130023
SupplementS005
Product CodePJK 
Advisory CommitteeGeneral & Plastic Surgery
Supplement Type135 Review Track For 30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address COHERA MEDICAL, INC 209 Sandusky Street pittsburg, PA 15212

Supplemental Filings

Supplement NumberDateSupplement Type
P130023Original Filing
S005 2017-01-26 135 Review Track For 30-day Notice
S004
S003 2016-05-09 30-day Notice
S002 2016-02-02 Normal 180 Day Track No User Fee
S001 2015-06-18 Special (immediate Track)

NIH GUDID Devices

Device IDPMASupp
M690TG100US0 P130023 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.